ArticleFrontiers in pharmacology2026

Targeting RSF1 with tanshinone I inhibits cervical cancer cell growth through modulation of NF-κB pathway.

Yuan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.